Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 8, 2014, Pages 3513-3518

  Raungrut, Pritsana ^a   Wongkotsila, Anusara ^a   Lirdprapamongkol, Kriengsak ^b   Svasti, Jisnuson ^b   Geater, Sarayut Lucien ^a   Phukaoloun, Monlika ^a   Suwiwat, Supaporn ^a   Thongsuksai, Paramee ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Krung Thep Maha Nakhon   (Thailand)

Author keywords

14 3 3 ; Immunohistochemistry; Invasion; Metastasis; Non small cell lung cancer

Indexed keywords

PROTEIN 14 3 3; TUMOR MARKER;

ADENOCARCINOMA; AGE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION;

14-3-3 PROTEINS; ADENOCARCINOMA; AGE FACTORS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901979305     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.8.3513     Document Type: Article

References (26)

1. Aitken A (2006). 14-3-3 proteins: a historic overview. Semin Cancer Biol, 16, 162-72.
2. Ajjappala BS, Kim YS, Kim MS, et al (2009). 14-3-3gamma is stimulated by IL-3 and promotes cell proliferation. J Immunol, 182, 1050-60.
3. Fu H, Subramanian RR, Masters SC (2000). 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol, 40, 617-47.
4. Herbst RS, Heymach JV, Lippman SM (2008). Lung cancer. N Engl J Med, 359, 1367-80.
5. Hermeking H (2003). The 14-3-3 cancer connection. Nat Rev Cancer, 3, 931-43.
6. Horie M, Suzuki M, Takahashi E, et al (1999). Cloning, expression, and chromosomal mapping of the human 14-3-3gamma gene (YWHAG) to 7q11.23. Genomics, 60, 241-3.
7. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
8. Jin YH, Kim YJ, Kim DW, et al (2008). Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochem Biophys Res Commun, 368, 690-5.
9. Ko BS, Lai IR, Chang TC, et al (2011). Involvement of 14-3-3gamma overexpression in extrahepatic metastasis of hepatocellular carcinoma. Hum Pathol, 42, 129-35.
10. Lirdprapamongkol K, Kramb JP, Suthiphongchai T, et al (2009). Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in vivo. J Agric Food Chem, 57, 3055-63.
11. Morrison DK (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol, 19, 16-23.
12. Peng CY, Graves PR, Thoma RS, et al (1997). Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277, 1501-05.
13. Qi W, Liu X, Chen W, et al (2003). Overexpression of 14-3-3gamma causes polyploidization in H322 lung cancer cells. Mol Carcinog, 46, 847-56.
14. Qi W, Liu X, Qiao D, et al (2005). Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer, 113, 359-63.
15. Radhakrishnan VM, Martinez JD (2010). 14-3-3gamma induces oncogenic transformation by stimulating MAP kinase and PI3K signaling. PLoS One, 5, 11433.
16. Radhakrishnan VM, Putnam CW, Qi W, et al (2011). P53 suppresses expression of the 14-3-3 gamma oncogene. BMC Cancer, 11, 378.
17. Samuel T, Weber HO, Rauch P, et al (2001). The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax. J Biol Chem, 276, 45201-06.
18. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
19. Song X, Chen X, Yamaguchi H, et al (2006). Initiation of cofilin activity in response to EGF is uncoupled from cofilin phosphorylation and dephosphorylation in carcinoma cells. J Cell Sci, 119, 2871-81.
20. Song Y, Yang Z, Ke Z, et al (2012). Expression of 14-3-3gamma in patients with breast cancer: correlation with clinicopathological features and prognosis. Cancer Epidemiol, 36, 533-6.
21. Umbricht CB, Evron E, Gabrielson E, et al (2001). Hypermethylation of 14-3-3σ (stratififin) is an early event in breast cancer. Oncogene, 20, 3348-53.
22. Wang W, Shakes DC (1996). Molecular evolution of the 14-3-3 protein family. J Mol Evol, 43, 384-98.
23. Wu Q, Liu CZ, Tau LY, et al (2012). The clinicopathological and prognostic impact of 14-3-3 protein isoforms expression in human cholangiocarcinoma by immunohistochemistry. Asian Pac J Cancer Prev, 13, 1253-9.
24. Xing H, Zhang S, Weinheimer C, et al (2000). 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J, 19, 349-58.
25. Youlden DR, Cramb SM, Baade PD (2008). The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol, 3, 819-31.
26. Yu XY, Zhang Z, Zhang GJ, Guo KF, Kong CZ (2012). Knockdown of Cdc25B in renal cell carcinoma is associated with decreased malignant features. Asian Pac J Cancer Prev, 13, 931-5.